{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:33:48Z","timestamp":1793730828333,"version":"4.6.1"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K012665"],"award-info":[{"award-number":["MR\/K012665"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S001697\/1"],"award-info":[{"award-number":["MR\/S001697\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/M011151\/1"],"award-info":[{"award-number":["BB\/M011151\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human papillomaviruses (HPV) are a major cause of malignancy worldwide, contributing to ~5% of all human cancers including almost all cases of cervical cancer and a growing number of ano-genital and oral cancers. HPV-induced malignancy is primarily driven by the viral oncogenes, E6 and E7, which manipulate host cellular pathways to increase cell proliferation and enhance cell survival, ultimately predisposing infected cells to malignant transformation. Consequently, a more detailed understanding of viral-host interactions in HPV-associated disease offers the potential to identify novel therapeutic targets. Here, we identify that the c-Jun N-terminal kinase (JNK) signalling pathway is activated in cervical disease and in cervical cancer. The HPV E6 oncogene induces JNK1\/2 phosphorylation in a manner that requires the E6 PDZ binding motif. We show that blockade of JNK1\/2 signalling using small molecule inhibitors, or knockdown of the canonical JNK substrate c-Jun, reduces cell proliferation and induces apoptosis in cervical cancer cells. We further demonstrate that this phenotype is at least partially driven by JNK-dependent activation of EGFR signalling via increased expression of EGFR and the EGFR ligands EGF and HB-EGF. JNK\/c-Jun signalling promoted the invasive potential of cervical cancer cells and was required for the expression of the epithelial to mesenchymal transition (EMT)-associated transcription factor Slug and the mesenchymal marker Vimentin. Furthermore, JNK\/c-Jun signalling is required for the constitutive expression of HPV E6 and E7, which are essential for cervical cancer cell growth and survival. Together, these data demonstrate a positive feedback loop between the EGFR signalling pathway and HPV E6\/E7 expression, identifying a regulatory mechanism in which HPV drives EGFR signalling to promote proliferation, survival and EMT. Thus, our study has identified a novel therapeutic target that may be beneficial for the treatment of cervical cancer.<\/jats:p>","DOI":"10.1038\/s41418-020-00693-9","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T10:05:51Z","timestamp":1607594751000},"page":"1669-1687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["E6-mediated activation of JNK drives EGFR signalling to promote proliferation and viral oncoprotein expression in cervical cancer"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-5450","authenticated-orcid":false,"given":"Ethan L.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0076-6853","authenticated-orcid":false,"given":"James A.","family":"Scarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6246-7181","authenticated-orcid":false,"given":"Molly R.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-4738","authenticated-orcid":false,"given":"Christopher W.","family":"Wasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia C.","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Barba-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-4693","authenticated-orcid":false,"given":"Andrew","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,10]]},"reference":[{"key":"693_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H Hausen zur","year":"2002","unstructured":"Hausen zur H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2:342\u201350.","journal-title":"Nat Rev Cancer"},{"key":"693_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382:889\u201399.","journal-title":"Lancet."},{"key":"693_CR3","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1038\/sj.onc.1208453","volume":"24","author":"B Zhang","year":"2005","unstructured":"Zhang B, Srirangam A, Potter DA, Roman A. HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene. 2005;24:2585\u20138.","journal-title":"Oncogene."},{"key":"693_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/oncotarget.803","volume":"4","author":"V Purpura","year":"2013","unstructured":"Purpura V, Belleudi F, Caputo S, Torrisi MR. HPV16 E5 and KGFR\/FGFR2b interplay in differentiating epithelial cells. Oncotarget. 2013;4:192\u2013205.","journal-title":"Oncotarget."},{"key":"693_CR5","doi-asserted-by":"publisher","first-page":"103581","DOI":"10.18632\/oncotarget.21658","volume":"8","author":"CW Wasson","year":"2017","unstructured":"Wasson CW, Morgan EL, M\u00fcller M, Ross RL, Hartley M, Roberts S, et al. Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle. Oncotarget. 2017;8:103581\u2013600.","journal-title":"Oncotarget."},{"key":"693_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1158\/0008-5472.CAN-19-1771","volume":"80","author":"S Miyauchi","year":"2020","unstructured":"Miyauchi S, Sanders PD, Guram K, Kim SS, Paolini F, Venuti A, et al. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer. Cancer Res. 2020;80:732\u201346.","journal-title":"Cancer Res"},{"key":"693_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993;75:495\u2013505.","journal-title":"Cell."},{"key":"693_CR8","first-page":"4620","volume":"56","author":"SN Boyer","year":"1996","unstructured":"Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 1996;56:4620\u20134.","journal-title":"Cancer Res"},{"key":"693_CR9","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1038\/sj.onc.1208935","volume":"24","author":"D Pim","year":"2005","unstructured":"Pim D, Massimi P, Dilworth SM, Banks L. Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene. 2005;24:7830\u20138.","journal-title":"Oncogene."},{"key":"693_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.virol.2008.09.040","volume":"383","author":"A Contreras-Paredes","year":"2009","unstructured":"Contreras-Paredes A, la Cruz-Hern\u00e1ndez DeE, Mart\u00ednez-Ram\u00edrez I, Due\u00f1as-Gonzalez A, Lizano M. E6 variants of human papillomavirus 18 differentially modulate the protein kinase B\/phosphatidylinositol 3-kinase (akt\/PI3K) signaling pathway. Virology. 2009;383:78\u201385.","journal-title":"Virology."},{"key":"693_CR11","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.3390\/v7082842","volume":"7","author":"JOM Bello","year":"2015","unstructured":"Bello JOM, Nieva LO, Paredes AC, Gonzalez AMF, Zavaleta LR, Lizano M. Regulation of the Wnt\/\u03b2-catenin signaling pathway by human papillomavirus E6 and E7 oncoproteins. Viruses. 2015;7:4734\u201355.","journal-title":"Viruses."},{"key":"693_CR12","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.15252\/emmm.201404976","volume":"7","author":"C He","year":"2015","unstructured":"He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, et al. The Hippo\/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Mol Med. 2015;7:1426\u201349.","journal-title":"EMBO Mol Med"},{"key":"693_CR13","doi-asserted-by":"publisher","first-page":"e1007835","DOI":"10.1371\/journal.ppat.1007835","volume":"15","author":"EL Morgan","year":"2019","unstructured":"Morgan EL, Macdonald A. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NF\u03baB-IL-6 signalling axis. PLoS Pathog. 2019;15:e1007835.","journal-title":"PLoS Pathog"},{"key":"693_CR14","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.3390\/cancers11121934","volume":"11","author":"EL Morgan","year":"2019","unstructured":"Morgan EL, Macdonald A. JAK2 inhibition impairs proliferation and sensitises cervical cancer cells to cisplatin-induced cell death. Cancers. 2019;11:1934.","journal-title":"Cancers"},{"key":"693_CR15","doi-asserted-by":"publisher","first-page":"e1008624","DOI":"10.1371\/journal.ppat.1008624","volume":"16","author":"EL Morgan","year":"2020","unstructured":"Morgan EL, Patterson MR, Ryder EL, Lee SY, Wasson CW, Harper KL, et al. MicroRNA-18a targeting of the STK4\/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer. PLoS Pathog. 2020;16:e1008624.","journal-title":"PLoS Pathog"},{"key":"693_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3390\/ijms21031102","volume":"21","author":"S Lee","year":"2020","unstructured":"Lee S, Rauch J, Kolch W. Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci. 2020;21:1102.","journal-title":"Int J Mol Sci"},{"key":"693_CR17","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1128\/JVI.02712-14","volume":"89","author":"A Satsuka","year":"2015","unstructured":"Satsuka A, Mehta K, Laimins L. p38MAPK and MK2 pathways are important for the differentiation-dependent human papillomavirus life cycle. J Virol. 2015;89:1919\u201324.","journal-title":"J Virol"},{"key":"693_CR18","doi-asserted-by":"publisher","first-page":"e1006282","DOI":"10.1371\/journal.ppat.1006282","volume":"13","author":"N Egawa","year":"2017","unstructured":"Egawa N, Wang Q, Griffin HM, Murakami I, Jackson D, Mahmood R, et al. HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions. PLoS Pathog. 2017;13:e1006282.","journal-title":"PLoS Pathog"},{"key":"693_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.antiviral.2018.08.005","volume":"158","author":"LF Wetherill","year":"2018","unstructured":"Wetherill LF, Wasson CW, Swinscoe G, Kealy D, Foster R, Griffin S, et al. Alkyl-imino sugars inhibit the pro-oncogenic ion channel function of human papillomavirus (HPV) E5. Antivir Res. 2018;158:113\u201321.","journal-title":"Antivir Res"},{"key":"693_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19:142\u20139.","journal-title":"Curr Opin Cell Biol"},{"key":"693_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1947601913486349","volume":"4","author":"C Tournier","year":"2013","unstructured":"Tournier C. The 2 faces of JNK signaling in cancer. Genes Cancer. 2013;4:397\u2013400.","journal-title":"Genes Cancer"},{"key":"693_CR22","first-page":"400","volume":"60","author":"L Xiao","year":"2000","unstructured":"Xiao L, Lang W. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells. Cancer Res. 2000;60:400\u20138.","journal-title":"Cancer Res"},{"key":"693_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1101\/gad.1062903","volume":"17","author":"NJ Kennedy","year":"2003","unstructured":"Kennedy NJ, Sluss HK, Jones SN, Bar-Sagi D, Flavell RA, Davis RJ. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 2003;17:629\u201337.","journal-title":"Genes Dev"},{"key":"693_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1128\/MCB.01122-10","volume":"31","author":"C Cellurale","year":"2011","unstructured":"Cellurale C, Sabio G, Kennedy NJ, Das M, Barlow M, Sandy P, et al. Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation. Mol Cell Biol. 2011;31:1565\u201376.","journal-title":"Mol Cell Biol"},{"key":"693_CR25","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1073\/pnas.92.25.11746","volume":"92","author":"AB Raitano","year":"1995","unstructured":"Raitano AB, Halpern JR, Hambuch TM, Sawyers CL. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci USA. 1995;92:11746\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ccr.2007.04.021","volume":"11","author":"I Vivanco","year":"2007","unstructured":"Vivanco I, Palaskas N, Tran C, Finn SP, Getz G, Kennedy NJ, et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell. 2007;11:555\u201369.","journal-title":"Cancer Cell"},{"key":"693_CR27","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/onc.2016.417","volume":"36","author":"X Xie","year":"2017","unstructured":"Xie X, Kaoud TS, Edupuganti R, Zhang T, Kogawa T, Zhao Y, et al. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun. Oncogene. 2017;36:2599\u2013608.","journal-title":"Oncogene."},{"key":"693_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7554\/eLife.36389","volume":"7","author":"N Girnius","year":"2018","unstructured":"Girnius N, Edwards YJ, Garlick DS, Davis RJ. The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation. Elife. 2018;7:27.","journal-title":"Elife."},{"key":"693_CR29","doi-asserted-by":"publisher","first-page":"e1006975","DOI":"10.1371\/journal.ppat.1006975","volume":"14","author":"EL Morgan","year":"2018","unstructured":"Morgan EL, Wasson CW, Hanson L, Kealy D, Pentland I, McGuire V, et al. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathog. 2018;14:e1006975.","journal-title":"PLoS Pathog"},{"key":"693_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3332\/ecancer.2015.526","volume":"9","author":"R Ghittoni","year":"2015","unstructured":"Ghittoni R, Accardi R, Chiocca S, Tommasino M. Role of human papillomaviruses in carcinogenesis. Ecancermedicalscience. 2015;9:526.","journal-title":"Ecancermedicalscience."},{"key":"693_CR31","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1128\/MMBR.00025-06","volume":"70","author":"MA Bogoyevitch","year":"2006","unstructured":"Bogoyevitch MA, Kobe B. Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev. 2006;70:1061\u201395.","journal-title":"Microbiol Mol Biol Rev"},{"key":"693_CR32","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1534-5807(03)00161-8","volume":"4","author":"R Zenz","year":"2003","unstructured":"Zenz R, Scheuch H, Martin P, Frank C, Eferl R, Kenner L, et al. c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. Dev Cell. 2003;4:879\u201389.","journal-title":"Dev Cell"},{"key":"693_CR33","first-page":"691","volume":"2","author":"JY Zhang","year":"2012","unstructured":"Zhang JY, Selim MA. The role of the c-Jun N-terminal Kinase signaling pathway in skin cancer. Am J Cancer Res. 2012;2:691\u20138.","journal-title":"Am J Cancer Res"},{"key":"693_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/353670a0","volume":"353","author":"BJ Pulverer","year":"1991","unstructured":"Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991;353:670\u20134.","journal-title":"Nature"},{"key":"693_CR35","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1093\/emboj\/cdg388","volume":"22","author":"S Morton","year":"2003","unstructured":"Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J. 2003;22:3876\u201386.","journal-title":"EMBO J"},{"key":"693_CR36","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.biocel.2007.06.013","volume":"39","author":"M Humar","year":"2007","unstructured":"Humar M, Loop T, Schmidt R, Hoetzel A, Roesslein M, Andriopoulos N, et al. The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun. Int J Biochem Cell Biol. 2007;39:2278\u201388.","journal-title":"Int J Biochem Cell Biol"},{"key":"693_CR37","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1158\/0008-5472.CAN-17-0369","volume":"77","author":"J Li","year":"2017","unstructured":"Li J, Akbani R, Zhao W, Lu Y, Weinstein JN, Mills GB, et al. Explore, visualize, and analyze functional cancer proteomic data using the cancer proteome atlas. Cancer Res. 2017;77:e51\u20134.","journal-title":"Cancer Res"},{"key":"693_CR38","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1074\/mcp.RA118.001260","volume":"18","author":"M-JM Chen","year":"2019","unstructured":"Chen M-JM, Li J, Wang Y, Akbani R, Lu Y, Mills GB, et al. TCPA v3.0: an integrative platform to explore the pan-cancer analysis of functional proteomic data. Mol Cell Proteom. 2019;18:S15\u201325.","journal-title":"Mol Cell Proteom"},{"key":"693_CR39","doi-asserted-by":"publisher","first-page":"7542","DOI":"10.1073\/pnas.1304855110","volume":"110","author":"E-Y Kho","year":"2013","unstructured":"Kho E-Y, Wang H-K, Banerjee NS, Broker TR, Chow LT. HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc Natl Acad Sci USA. 2013;110:7542\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR40","first-page":"4918","volume":"13","author":"JM Huibregtse","year":"1993","unstructured":"Huibregtse JM, Scheffner M, Howley PM. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol Cell Biol. 1993;13:4918\u201327.","journal-title":"Mol Cell Biol"},{"key":"693_CR41","doi-asserted-by":"publisher","first-page":"9463","DOI":"10.1128\/JVI.01234-13","volume":"87","author":"CP Delury","year":"2013","unstructured":"Delury CP, Marsh EK, James CD, Boon SS, Banks L, Knight GL, et al. The role of protein kinase A regulation of the E6 PDZ-binding domain during the differentiation-dependent life cycle of human papillomavirus type 18. J Virol. 2013;87:9463\u201372.","journal-title":"J Virol"},{"key":"693_CR42","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1073\/pnas.251194298","volume":"98","author":"BL Bennett","year":"2001","unstructured":"Bennett BL, Sasaki DT, Murray BW, O\u2019Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA. 2001;98:13681\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.chembiol.2011.11.010","volume":"19","author":"T Zhang","year":"2012","unstructured":"Zhang T, Inesta-Vaquera F, Niepel M, Zhang J, Ficarro SB, Machleidt T, et al. Discovery of potent and selective covalent inhibitors of JNK. Chem Biol. 2012;19:140\u201354.","journal-title":"Chem Biol"},{"key":"693_CR44","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0092-8674(88)90143-2","volume":"55","author":"P Angel","year":"1988","unstructured":"Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun\/AP-1. Cell. 1988;55:875\u201385.","journal-title":"Cell."},{"key":"693_CR45","first-page":"3908","volume":"61","author":"N Chen","year":"2001","unstructured":"Chen N, Nomura M, She QB, Ma WY, Bode AM, Wang L, et al. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res. 2001;61:3908\u201312.","journal-title":"Cancer Res"},{"key":"693_CR46","first-page":"1343","volume":"62","author":"Q-B She","year":"2002","unstructured":"She Q-B, Chen N, Bode AM, Flavell RA, Dong Z. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 2002;62:1343\u20138.","journal-title":"Cancer Res"},{"key":"693_CR47","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/j.1460-2075.1996.tb00636.x","volume":"15","author":"S Gupta","year":"1996","unstructured":"Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, D\u00e9rijard B, et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996;15:2760\u201370.","journal-title":"EMBO J"},{"key":"693_CR48","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.celrep.2015.12.104","volume":"14","author":"X Liu","year":"2016","unstructured":"Liu X, Li H, Rajurkar M, Li Q, Cotton JL, Ou J, et al. Tead and AP1 coordinate transcription and motility. Cell Rep. 2016;14:1169\u201380.","journal-title":"Cell Rep."},{"key":"693_CR49","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration.","year":"2008","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol. 2008;26:5802\u201312.","journal-title":"J Clin Oncol"},{"key":"693_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.canlet.2014.09.021","volume":"356","author":"R Qureshi","year":"2015","unstructured":"Qureshi R, Arora H, Rizvi MA. EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett. 2015;356:321\u201331.","journal-title":"Cancer Lett"},{"key":"693_CR51","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1242\/jcs.019455","volume":"121","author":"JF Alcorn","year":"2008","unstructured":"Alcorn JF, Guala AS, van der Velden J, McElhinney B, Irvin CG, Davis RJ, et al. Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci. 2008;121:1036\u201345.","journal-title":"J Cell Sci"},{"key":"693_CR52","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.15252\/embj.201490693","volume":"34","author":"SK Sahu","year":"2015","unstructured":"Sahu SK, Garding A, Tiwari N, Thakurela S, Toedling J, Gebhard S, et al. JNK-dependent gene regulatory circuitry governs mesenchymal fate. EMBO J. 2015;34:2162\u201381.","journal-title":"EMBO J"},{"key":"693_CR53","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S1534-5807(03)00159-X","volume":"4","author":"G Li","year":"2003","unstructured":"Li G, Gustafson-Brown C, Hanks SK, Nason K, Arbeit JM, Pogliano K, et al. c-Jun is essential for organization of the epidermal leading edge. Dev Cell. 2003;4:865\u201377.","journal-title":"Dev Cell"},{"key":"693_CR54","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/dev.02030","volume":"132","author":"N Mine","year":"2005","unstructured":"Mine N, Iwamoto R, Mekada E. HB-EGF promotes epithelial cell migration in eyelid development. Development. 2005;132:4317\u201326.","journal-title":"Development."},{"key":"693_CR55","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1128\/MCB.25.12.5040-5051.2005","volume":"25","author":"A Mialon","year":"2005","unstructured":"Mialon A, Sankinen M, S\u00f6derstr\u00f6m H, Junttila TT, Holmstr\u00f6m T, Koivusalo R, et al. DNA topoisomerase I is a cofactor for c-Jun in the regulation of epidermal growth factor receptor expression and cancer cell proliferation. Mol Cell Biol. 2005;25:5040\u201351.","journal-title":"Mol Cell Biol"},{"key":"693_CR56","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/sj.onc.1209999","volume":"26","author":"F Wang","year":"2007","unstructured":"Wang F, Liu R, Lee SW, Sloss CM, Couget J, Cusack JC. Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance. Oncogene. 2007;26:2006\u201316.","journal-title":"Oncogene."},{"key":"693_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1042\/BJ20140103","volume":"463","author":"Y Fang","year":"2014","unstructured":"Fang Y, Wang Y, Wang Y, Meng Y, Zhu J, Jin H, et al. A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK\/c-Jun pathway inhibition. Biochem J. 2014;463:383\u201392.","journal-title":"Biochem J"},{"key":"693_CR58","doi-asserted-by":"publisher","first-page":"e1003237","DOI":"10.1371\/journal.ppat.1003237","volume":"9","author":"JM Spangle","year":"2013","unstructured":"Spangle JM, M\u00fcnger K. The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog. 2013;9:e1003237.","journal-title":"PLoS Pathog"},{"key":"693_CR59","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1128\/JVI.77.2.1551-1563.2003","volume":"77","author":"RA DeFilippis","year":"2003","unstructured":"DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol. 2003;77:1551\u201363.","journal-title":"J Virol"},{"key":"693_CR60","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1128\/jvi.67.11.6476-6486.1993","volume":"67","author":"K Butz","year":"1993","unstructured":"Butz K, Hoppe-Seyler F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J Virol. 1993;67:6476\u201386.","journal-title":"J Virol"},{"key":"693_CR61","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/viro.1995.1390","volume":"211","author":"S Kyo","year":"1995","unstructured":"Kyo S, Tam A, Laimins LA. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology 1995;211:184\u201397.","journal-title":"Virology"},{"key":"693_CR62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/jvi.71.1.362-370.1997","volume":"71","author":"F R\u00f6sl","year":"1997","unstructured":"R\u00f6sl F, Das BC, Lengert M, Geletneky K, Hausen zur H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol. 1997;71:362\u201370.","journal-title":"J Virol"},{"key":"693_CR63","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1101\/gad.988902","volume":"16","author":"C Talora","year":"2002","unstructured":"Talora C, Sgroi DC, Crum CP, Dotto GP. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6\/E7 expression and late steps of malignant transformation. Genes Dev. 2002;16:2252\u201363.","journal-title":"Genes Dev"},{"key":"693_CR64","doi-asserted-by":"publisher","first-page":"45408","DOI":"10.1074\/jbc.M401818200","volume":"279","author":"J De-Castro Arce","year":"2004","unstructured":"De-Castro Arce J, Soto U, van Riggelen J, Schwarz E, Hausen zur H, R\u00f6sl F. Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells. J Biol Chem. 2004;279:45408\u201316.","journal-title":"J Biol Chem"},{"key":"693_CR65","doi-asserted-by":"publisher","first-page":"28520","DOI":"10.1074\/jbc.M702870200","volume":"282","author":"J De-Castro Arce","year":"2007","unstructured":"De-Castro Arce J, G\u00f6ckel-Krzikalla E, R\u00f6sl F. Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem. 2007;282:28520\u20139.","journal-title":"J Biol Chem"},{"key":"693_CR66","doi-asserted-by":"publisher","first-page":"16201","DOI":"10.1038\/nmicrobiol.2016.201","volume":"2","author":"S Schumann","year":"2016","unstructured":"Schumann S, Jackson BR, Yule I, Whitehead SK, Revill C, Foster R, et al. Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach. Nat Microbiol. 2016;2:16201.","journal-title":"Nat Microbiol"},{"key":"693_CR67","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1158\/1078-0432.CCR-16-2203","volume":"23","author":"TM Brand","year":"2017","unstructured":"Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, et al. Human papillomavirus regulates her3 expression in head and neck cancer: implications for targeted HER3 therapy in HPV+ patients. Clin Cancer Res. 2017;23:3072\u201383.","journal-title":"Clin Cancer Res"},{"key":"693_CR68","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1002\/jcb.26118","volume":"118","author":"A Bahrami","year":"2017","unstructured":"Bahrami A, Hasanzadeh M, Hassanian SM, ShahidSales S, Ghayour-Mobarhan M, Ferns GA, et al. The potential value of the PI3K\/Akt\/mTOR signaling pathway for assessing prognosis in cervical cancer and as a target for therapy. J Cell Biochem. 2017;118:4163\u20139.","journal-title":"J Cell Biochem"},{"key":"693_CR69","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.15252\/emmm.201404976","volume":"7","author":"C He","year":"2015","unstructured":"He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, et al. The Hippo\/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Mol Med. 2015;7:1426\u201349.","journal-title":"EMBO Mol Med"},{"key":"693_CR70","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1093\/emboj\/16.10.2634","volume":"16","author":"GA Rodrigues","year":"1997","unstructured":"Rodrigues GA, Park M, Schlessinger J. Activation of the JNK pathway is essential for transformation by the Met oncogene. EMBO J. 1997;16:2634\u201345.","journal-title":"EMBO J"},{"key":"693_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-019-0060-y","volume":"4","author":"L Zhao","year":"2019","unstructured":"Zhao L, Wang L, Zhang C, Liu Z, Piao Y, Yan J, et al. E6-induced selective translation of WNT4 and JIP2 promotes the progression of cervical cancer via a noncanonical WNT signaling pathway. Signal Transduct Target Ther. 2019;4:32.","journal-title":"Signal Transduct Target Ther"},{"key":"693_CR72","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3:859\u201368.","journal-title":"Nat Rev Cancer"},{"key":"693_CR73","first-page":"77","volume":"30","author":"J de Wilde","year":"2008","unstructured":"de Wilde J, De-Castro Arce J, Snijders PJF, Meijer CJLM, R\u00f6sl F, Steenbergen RDM. Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol. 2008;30:77\u201387.","journal-title":"Cell Oncol"},{"key":"693_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1476-4598-10-39","volume":"10","author":"S Mahata","year":"2011","unstructured":"Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer. 2011;10:39\u201314.","journal-title":"Mol Cancer"},{"key":"693_CR75","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.1158\/0008-5472.CAN-04-2618","volume":"65","author":"C Kuntzen","year":"2005","unstructured":"Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, et al. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2\/M cell cycle arrest. Cancer Res. 2005;65:6780\u20138. 1","journal-title":"Cancer Res"},{"key":"693_CR76","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3858\/emm.2009.41.9.073","volume":"41","author":"DO Moon","year":"2009","unstructured":"Moon DO, Kim MO, Kang CH, Lee JD, Choi YH, Kim GY. JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2\/M phase arrest, endoreduplication, and delayed apoptosis. Exp Mol Med. 2009;41:665\u201377.","journal-title":"Exp Mol Med"},{"key":"693_CR77","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13039-016-0296-y","volume":"9","author":"D Mili","year":"2016","unstructured":"Mili D, Abid K, Rjiba I, Kenani A. Effect of SP600125 on the mitotic spindle in HeLa Cells, leading to mitotic arrest, endoreduplication and apoptosis. Mol Cytogenet. 2016;9:86\u20137.","journal-title":"Mol Cytogenet"},{"key":"693_CR78","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.1073\/pnas.0406061101","volume":"101","author":"CR Weston","year":"2004","unstructured":"Weston CR, Wong A, Hall JP, Goad MEP, Flavell RA, Davis RJ. The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis. Proc Natl Acad Sci USA. 2004;101:14114\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR79","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/cdd.2010.22","volume":"17","author":"A Meixner","year":"2010","unstructured":"Meixner A, Karreth F, Kenner L, Penninger JM, Wagner EF. Jun and JunD-dependent functions in cell proliferation and stress response. Cell Death Differ. 2010;17:1409\u201319.","journal-title":"Cell Death Differ"},{"key":"693_CR80","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.95.12.6809","volume":"95","author":"LM Wang","year":"1998","unstructured":"Wang LM, Kuo A, Alimandi M, Veri MC, Lee CC, Kapoor V, et al. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4. Proc Natl Acad Sci USA. 1998;95:6809\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"693_CR81","doi-asserted-by":"publisher","first-page":"e103440","DOI":"10.1371\/journal.pone.0103440","volume":"9","author":"E Zhang","year":"2014","unstructured":"Zhang E, Feng X, Liu F, Zhang P, Liang J, Tang X. Roles of PI3K\/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1\u03b1, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. PLoS ONE. 2014;9:e103440.","journal-title":"PLoS ONE"},{"key":"693_CR82","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1038\/onc.2008.351","volume":"27","author":"M Thomas","year":"2008","unstructured":"Thomas M, Narayan N, Pim D, Tomai\u0107 V, Massimi P, Nagasaka K, et al. Human papillomaviruses, cervical cancer and cell polarity. Oncogene. 2008;27:7018\u201330.","journal-title":"Oncogene."},{"key":"693_CR83","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.cub.2006.04.042","volume":"16","author":"T Igaki","year":"2006","unstructured":"Igaki T, Pagliarini RA, Xu T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol. 2006;16:1139\u201346.","journal-title":"Curr Biol"},{"key":"693_CR84","doi-asserted-by":"publisher","first-page":"e1005789","DOI":"10.1371\/journal.ppat.1005789","volume":"12","author":"M Padash Barmchi","year":"2016","unstructured":"Padash Barmchi M, Gilbert M, Thomas M, Banks L, Zhang B, Auld VJ. A Drosophila model of HPV E6-induced malignancy reveals essential roles for magi and the insulin receptor. PLoS Pathog. 2016;12:e1005789.","journal-title":"PLoS Pathog"},{"key":"693_CR85","first-page":"450","volume":"2","author":"TP Cripe","year":"1990","unstructured":"Cripe TP, Alderborn A, Anderson RD, Parkkinen S, Bergman P, Haugen TH, et al. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules. N Biol. 1990;2:450\u201363.","journal-title":"N Biol"},{"key":"693_CR86","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1099\/0022-1317-76-8-1945","volume":"76","author":"M Peto","year":"1995","unstructured":"Peto M, Tolle-Ers\u00fc I, Kreysch HG, Klock G. Epidermal growth factor induction of human papillomavirus type 16 E6\/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer. J Gen Virol. 1995;76:1945\u201358.","journal-title":"J Gen Virol"},{"key":"693_CR87","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1098-2744(200002)27:2<97::AID-MC5>3.0.CO;2-V","volume":"27","author":"D Gaiotti","year":"2000","unstructured":"Gaiotti D, Chung J, Iglesias M, Nees M, Baker PD, Evans CH, et al. Tumor necrosis factor-alpha promotes human papillomavirus (HPV) E6\/E7 RNA expression and cyclin-dependent kinase activity in HPV-immortalized keratinocytes by a ras-dependent pathway. Mol Carcinog. 2000;27:97\u2013109.","journal-title":"Mol Carcinog"},{"key":"693_CR88","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A. IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE. 2014;9:e96801.","journal-title":"PLoS ONE"},{"key":"693_CR89","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jcp.48.9.876","volume":"48","author":"S Detre","year":"1995","unstructured":"Detre S, Saclani Jotti G, Dowsett MA. \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 1995;48:876\u20138.","journal-title":"J Clin Pathol"},{"key":"693_CR90","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.virol.2011.01.007","volume":"412","author":"GL Knight","year":"2011","unstructured":"Knight GL, Pugh AG, Yates E, Bell I, Wilson R, Moody CA, et al. A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2\/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology. 2011;412:196\u2013210.","journal-title":"Virology."},{"key":"693_CR91","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1099\/vir.0.80734-0","volume":"86","author":"A Macdonald","year":"2005","unstructured":"Macdonald A, Mazaleyrat S, McCormick C, Street A, Burgoyne NJ, Jackson RM, et al. Further studies on hepatitis C virus NS5A-SH3 domain interactions: identification of residues critical for binding and implications for viral RNA replication and modulation of cell signalling. J Gen Virol. 2005;86:1035\u201344.","journal-title":"J Gen Virol"},{"key":"693_CR92","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1038\/sj.onc.1205878","volume":"21","author":"M Jiang","year":"2002","unstructured":"Jiang M, Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene. 2002;21:6041\u20138.","journal-title":"Oncogene."},{"key":"693_CR93","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1128\/JVI.77.10.6066-6069.2003","volume":"77","author":"AHS Hall","year":"2003","unstructured":"Hall AHS, Alexander KA. RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells. J Virol. 2003;77:6066\u20139.","journal-title":"J Virol"},{"key":"693_CR94","first-page":"260","volume":"10","author":"D Das","year":"2019","unstructured":"Das D, Bristol ML, Smith NW, James CD, Wang X, Pichierri P, et al. Werner helicase control of human papillomavirus 16 E1-E2 DNA replication is regulated by SIRT1 deacetylation. MBio. 2019;10:260.","journal-title":"MBio."},{"key":"693_CR95","doi-asserted-by":"publisher","first-page":"e2005752","DOI":"10.1371\/journal.pbio.2005752","volume":"16","author":"I Pentland","year":"2018","unstructured":"Pentland I, Campos-Le\u00f3n K, Cotic M, Davies K-J, Wood CD, Groves IJ, et al. Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription. PLoS Biol. 2018;16:e2005752.","journal-title":"PLoS Biol"},{"key":"693_CR96","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402\u20138.","journal-title":"Methods."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00693-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00693-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00693-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T02:03:34Z","timestamp":1674785014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-020-00693-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":96,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1038\/s41418-020-00693-9","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}